Search results
Results From The WOW.Com Content Network
Drugs is a peer-reviewed medical journal published by Adis International (Springer Nature) that covers topics in drugs and therapeutics. Besides research articles, the journal also publishes "Adis Drug Evaluations and AdisInsight Reports", evidence-based, single-agent reviews.
The Journal of Studies on Alcohol and Drugs (JSAD) is a peer-reviewed scientific journal that publishes original research articles on various aspects of the use and misuse of alcohol and other drugs. Topics covered include the biological, medical, epidemiological, social, psychological, and legal aspects of alcohol and other drug use, abuse ...
"Substance use pertains to using select substances such as alcohol, tobacco, illicit drugs, etc. that can cause dependence or harmful side effects."On the other hand, substance abuse is the use of drugs such as prescriptions, over-the-counter medications, or alcohol for purposes other than what they are intended for or using them in excessive ...
NIDA has also conducted research into diseases associated with drug use, such as AIDS and Hepatitis. NIDA views drug treatment as a means of modifying risky behavior such as unprotected sex and sharing needles. NIDA has also funded studies dealing with harm reduction. A NIDA-supported study on pregnant drug users noted, "professionals in ...
The American Journal of Drug and Alcohol Abuse is a bimonthly peer-reviewed medical journal covering all aspects of addiction. It was established in 1974 and is published by Taylor & Francis . The editor-in-chief is Bryon Adinoff ( University of Texas Southwestern Medical Center ).
The Journal of Psychoactive Drugs is a peer-reviewed medical journal on psychoactive drugs. It was established in 1967 by David E. Smith and is currently published five times per year by Taylor & Francis. It was previously titled Journal of Psychedelic Drugs until 1980.
An appropriate drug policy relies on the assessment of drug-related public expenditure based on a classification system where costs are properly identified. Labelled drug-related expenditures are defined as the direct planned spending that reflects the voluntary engagement of the state in the field of illicit drugs.
The four journals cover developments across the breadth of therapeutic areas and technologies relevant to the drug discovery and development pipeline. However, as of 2022, these titles have been discontinued and incorporated back into Drug Discovery Today. According to the Journal Citation Reports, the journal has a 2022 impact factor of 8.2. [1]